Skip to main content
Education and Training

AtriCure is committed to providing the most recent and relevant education. We recognize the importance of this material as a key component in giving the HealthCare Provider (HCP) access to the knowledge and experience required to assure optimal safety and outcomes in the atrial fibrillation patient population. This section contains educational materials and activities intended to enhance the user’s experience.
 

Advanced Training Courses (US)

 

Advanced Ablation Course

AtriCure is dedicated to continuously updating and improving our training programs. Our goal is to provide HealthCare Providers (HCPs) with educational courses that will allow them to adapt to evolving products and techniques. These educational and training programs are designed with significant input and counsel by an Education Steering Committee comprised of the world’s leading experts in their field to help individuals at varying experience levels learn more about the surgical treatment of atrial fibrillation. The program is focused on helping practitioners expand their expertise and improving patient care.

The Advanced Ablation Course: Cox Maze IV is unique in that it is the first and ONLY training course to focus on concomitant surgical treatment for persistent and long-standing persistent atrial fibrillation. The Society of Thoracic Surgeons has endorsed AtriCure’s Advanced Ablation Course in the United States.

2022 Advanced Ablation Courses available:
  • February 5-6: Newport Beach, CA
  • April 1-2: Jupiter, FL
  • May 20-21: Park City, UT
  • June 25-26: Nashville, TN
  • October 7-8: Austin, TX
  • November 5-6: New York City, NY

Interested In Attending? Learn More

Advanced Ablation Cover

Advanced Hybrid Ablation Course

The Advanced Hybrid Ablation Course was developed as a result of the published positive outcomes of Hybrid AF Convergent Therapy procedures and the recent FDA approval of the EPi-Sense Hybrid Coagulation system for long-standing persistent atrial fibrillation patients. This program focuses on the rationale, safety and efficacy of performing Hybrid AF Therapy.

This course faculty consists of Electrophysiologists and Cardiac Surgeons, many of whom were active in the CONVERGE IDE Trial. Attendee interaction, sharing of anecdotal experience and observations and group discussion is highly encouraged. This program is designed for Electrophysiologists, Cardiac surgeons, and Advanced Practice providers interested in the collaborative hybrid approach to treating long-standing persistent atrial fibrillation patients.

2022 Advanced Hybrid Ablation Courses available:
  • February 4-5: Phoenix, AZ
  • February 24: Salt Lake City, UT
  • March 26-27: Charlotte, NC
  • April 27-28: San Francisco, CA
  • May 21-22: Boston, MA
  • June 24-25: Austin, TX
  • July 29-30: Chicago, IL
  • August 26-27: La Jolla, CA
  • September 24-25: New York, NY
  • October 21-22: Dallas, TX
  • November 11-12: St. Helena, CA
  • December 2-3: Miami, FL

Interested In Attending? Learn More

Hybrid AF Convergent Therapy
Epicardial ablation
Minimally invasive epicardial ablation - left posterior atrial wall

The TRAC-AF Registry is an online resource developed to assist surgeons, cardiologists, and electrophysiologists in accurately and efficiently collecting patient specific data on ablation procedures, as well as patient outcomes. The tool was developed in collaboration with leading ablation physicians and nurses to be aligned with the HRS Expert Guidelines for Afib outcomes. Data capture and input is simple enough for centers without full time data collection staff while simultaneously providing meaningful data analysis. The Maze IV is the only comprehensive ablation registry that provides individual centers complete control over their data and outcomes reporting as neither the sponsor nor other sites, can access data outside of their center. We believe the registry will improve patient outcomes, and liaise to strengthen relationships between surgeons and referring physicians. This resource will provide data on the impact of ablation procedures, making it is easier to share comparative results with referring physicians in a systematic, objective reporting format.

Click Here to Request a TRAC-AF Registry Demonstration

TRAC-AF Logo

AtriCure recognizes the role of the Advanced Practice Provider (APP) is critical in assuring patients receive coordinated, multi-disciplinary care that follows evidenced-based ‘best practice’ pathways. Treatment pathways include thorough screening to identify atrial fibrillation (AF) patients, managing risk factors/co-morbidities, and referring patients to the appropriate care setting and therapy. These programs can be given on-site or online to single or multiple hospital networks.

“Comprehensive AF Patient Management - Integrated Clinic Services” 
This one-hour program is delivered by an Advanced Practice Provider (NP or PA) who discusses the building blocks for a multi-disciplinary AF clinic, essential team members and responsibilities, and the rationale for Hybrid AF Therapy in the patient’s treatment protocol. The class is focused for any APP involved in the continuum of AF patient care.
Interested In Attending? Learn More 

“The Role of the Advanced Practice Provider in the Surgical Treatment of Afib” 
This one-hour program focuses on the patient receiving concomitant AF surgical ablation while also undergoing open heart surgery. Many patients with long-standing persistent atrial fibrillation, who are being treated for structural heart disease or having bypass surgery, fail to have their AF treated. APPs are given the fundamentals of the Cox MAZE IV procedure and importance of supporting the surgeon to provide a complete bi-atrial lesion set. This class is intended for any APP interested in pre, intra, and post-operative surgical ablation.
Interested In Attending? Learn More

Education and Training

Hybrid AF Convergent Therapy” 
This one-hour CEU program offers a detailed and comprehensive lecture to serve as a guide in developing a Hybrid AF Therapy program for the treatment of long-standing persistent atrial fibrillation. Included are clinical insights and best practices across the perioperative spectrum compiled from hospitals with extensive experience in Hybrid AF Convergent Therapy. This class is intended for any Clinic/CVOR Nurse and Allied Health personnel who are part of the hospital’s AF organizational care plan. Interested In Attending? Learn More

On-Demand videos are available for viewing which outline the Hybrid AF Convergent procedure. 

  • Hybrid AF Therapy”- animated step-by-step technique for subxiphoid access to the posterior wall of the left atria to ablate with the EPi-Sense catheter.
  • Converge Clinical Study” The only prospective, multicenter superiority retrospective clinical trial - the highest level of evidence. The CONVERGE Study with the EPi-Sense System is the only FDA-approved minimally invasive ablation therapy of its kind to treat patients diagnosed with long-standing persistent atrial fibrillation. Click here to view

International

For more information about our international training courses, visit AF Connect.
(link is external)

PE-US-0160C-1223-G